GlycoMimetics (GLYC)
(Delayed Data from NSDQ)
$1.64 USD
-0.07 (-4.09%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $1.76 +0.12 (7.32%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Price, Consensus and EPS Surprise
GLYC 1.64 -0.07(-4.09%)
Will GLYC be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for GLYC based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for GLYC
Should You Buy GlycoMimetics (GLYC) Ahead of Earnings?
Is Axonics (AXNX) Outperforming Other Medical Stocks This Year?
GLYC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is GlycoMimetics (GLYC) Outperforming Other Medical Stocks This Year?
After Golden Cross, GlycoMimetics (GLYC)'s Technical Outlook is Bright
Are Medical Stocks Lagging Axonics (AXNX) This Year?
Other News for GLYC
GlycoMimetics to Report First Quarter 2024 Financial Results on May 9, 2024
GLYC, APLD and AUTL are among after hour movers
NIU, HEAR and SGH are among after hour movers
Largest borrow rate increases among liquid names
12 Health Care Stocks Moving In Tuesday's After-Market Session